Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05747703 · ClinicalTrials.gov registry record · NA

Telehealth Treatment for Alcohol Use Disorder

A NA study of Alcohol Use Disorder and Alcoholism, sponsored by Ria Health.

Active
Registry status
NA
Development phase
135
Enrollment target
1
Study location

NCT05747703 is a NA study of Alcohol Use Disorder and Alcoholism that is active but no longer recruiting, run by Ria Health. The registered enrollment target is 135 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05747703, a NA study of Alcohol Use Disorder and Alcoholism, is active but no longer recruiting, sponsored by Ria Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
135 participants
Enrollment target
1
Study location

Study Summary

Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.

Interventions

  • COMBINATION_PRODUCT Ria Treatment Platform

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2024-01-31
Est. Completion 2026-09
Phase NA

Sponsor

Ria Health

1 total trials

What the Registry Record Tells You About NCT05747703

The ClinicalTrials.gov registry entry for NCT05747703 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (59% lower). The listed sponsor is Ria Health, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Ria Treatment Platform is the first listed.

NCT05747703 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05747703 about?

NCT05747703 is a clinical study titled "Telehealth Treatment for Alcohol Use Disorder". Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational vide...

What is the current status of trial NCT05747703?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 135 participants. The study started on 2024-01-31. Estimated completion is 2026-09.

What conditions does trial NCT05747703 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Alcoholism, Alcohol Dependence.

What interventions are being tested in trial NCT05747703?

The interventions under investigation include: Ria Treatment Platform (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05747703?

This trial is sponsored by Ria Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05747703 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.